SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Acquisition

1 Apr 2019 07:00

RNS Number : 5782U
CLS Holdings PLC
01 April 2019
 

 

Release date: 1 April 2019

Embargoed until: 07:00 am

 

 

 

CLS Holdings plc

("CLS", the "Group", the "Company")

announces the acquisition of PURO, Adalperostrasse 82-86, Ismaning, Munich

 

CLS announces that it has exchanged contracts to acquire PURO, a multi-let office building in Munich, for €32.0 million excluding costs. The purchase price reflects a net initial yield of 5.1%; the reversionary yield is estimated to be 6.4%.

 

The property comprises 140,717 sq ft (13,073 sqm) of office space over three floors and is let to nine tenants, providing a WAULT of 4.9 years. The contracted annual rent of €1.73 million equates to an average of €11.00 per sqm per month, and with an ERV of €13.50 per sqm per month, presents significant opportunities for rental growth. In 2018, average rents in Munich were reported by Colliers to have increased by around 10% and, with vacancy rates in Munich below 2%, we expect rental growth to continue.

 

The Company expects to spend €3.0 million to improve the building, including converting lower ground storage into further offices.

 

Located within the established office area of Ismaning, between the city centre and the airport, the property benefits from excellent transport links and proximity to a variety of amenities for tenants. The building is leased to IT, telecommunications, manufacturing and healthcare companies.

 

CLS intends to finance the acquisition through cash resources and local bank debt.

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"We are delighted to acquire PURO in Ismaning, an area of Munich in which we have been looking to invest for some time. We remain committed to building an increasingly geographically diverse portfolio and this acquisition will further strengthen our presence in Germany. PURO will allow us to use our local expertise and active management capabilities to drive rents over the long term.

 

-ends-

 

 

For further information, please contact:

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

John Whiteley, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital Limited

Richard Crawley

Jamie Richards

+44 (0)20 3100 2222

 

Whitman Howard

Hugh Rich

+44 (0)20 7659 1261

 

Elm Square Advisers Limited

Jonathan Gray

+44 (0)20 7823 3695

 

Smithfield Consultants (Financial PR)Alex Simmons

Rob Yates

+44 (0)20 3047 2546

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQGMGFFRMLGLZM
Date   Source Headline
11th Jun 20264:28 pmRNSDirector/PDMR Shareholding
2nd Jun 202610:23 amRNSDirector/PDMR Shareholding
29th May 202612:00 pmRNSTotal Voting Rights
28th May 20264:20 pmRNSDirector/PDMR Shareholding
26th May 20264:38 pmRNSTR-1: Notification of major holdings
22nd May 20265:04 pmRNSAdmission of Further Securities to Trading
15th May 20261:05 pmRNSApplication for Listing - Enhanced Scrip Dividend
13th May 202612:07 pmRNSDirector/PDMR Shareholding
30th Apr 20261:05 pmRNSDirector/PDMR Shareholding
29th Apr 20262:12 pmRNSDirector/PDMR Shareholding
27th Apr 20267:00 amRNSCLS announces sale of The Brix, Essen
23rd Apr 20264:00 pmRNSResult of AGM
16th Apr 20262:59 pmRNSScrip Dividend Reference Share Price
15th Apr 202612:32 pmRNSDirector/PDMR Shareholding
9th Apr 20263:07 pmRNSTR-1: Notification of major holdings
25th Mar 20269:58 amRNSTR-1: Notification of major holdings
23rd Mar 20264:05 pmRNSPublication of 2025 Annual Report & Notice of AGM
16th Mar 20265:46 pmRNSDirector/PDMR Shareholding
13th Mar 20263:45 pmRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSAnnual Financial Results
13th Mar 20267:00 amRNSAnnual Financial Results
10th Feb 20264:03 pmRNSDirector/PDMR Shareholding
13th Jan 20264:37 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:30 pmRNSChanges to the responsibilities of a director
22nd Dec 20253:30 pmRNSChanges to the responsibilities of a director
22nd Dec 20257:00 amRNSCitadel Place: Conditional sale & Planning update
22nd Dec 20257:00 amRNSCitadel Place: Conditional sale & Planning update
9th Dec 20253:12 pmRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSTrading Update
12th Nov 20254:12 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSBoard Change/CFO Appointment
16th Oct 20257:00 amRNSCLS leases 14,700 sqm at Gotic Haus, Dortmund
10th Oct 202511:00 amRNSDirector/PDMR Shareholding
15th Sep 20259:00 amRNSTR-1 Notification of Major Holdings
9th Sep 20253:48 pmRNSDirector/PDMR Shareholding
14th Aug 20255:13 pmRNSDirector/PDMR Shareholding
13th Aug 20257:01 amRNSHalf Yearly Results Announcement 2025
13th Aug 20257:00 amRNSBoard Appointment
11th Aug 20256:11 pmRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSCLS secures over 8,000 sq. ft at The Coade
6th Aug 20257:00 amRNSCLS leases 2,165 sqm in Cologne
9th Jul 20259:49 amRNSDirector/PDMR Shareholding
3rd Jul 20251:51 pmRNSDirector/PDMR Shareholding
2nd Jul 20251:34 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCLS sells two properties in Germany
30th Jun 202511:48 amRNSBoard Change
11th Jun 20253:44 pmRNSDirector/PDMR Shareholding
3rd Jun 20252:57 pmRNSDirector/PDMR Shareholding
16th May 20254:35 pmRNSResult of AGM
13th May 20254:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.